✦ LIBER ✦

Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial

✍ Scribed by Primo N. Lara Jr; Jeff Longmate; Karen Reckamp; Barbara Gitlitz; Athanassios Argiris; Suresh Ramalingam; Chandra P. Belani; Philip C. Mack; Derick H.M. Lau; Mariana Koczywas; John J. Wright; Frances A. Shepherd; Natasha Leighl; David R. Gandara

Book ID: 115076795
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 119 KB
Volume: 12
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2011.n.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel plus cisplatin versus docetaxe

Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Phase I/II trial of gemcitabine plus doc

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

Randomized phase II trial comparing tras

Randomized phase II trial comparing trastuzumab plus weekly docetaxel versus trastuzumab plus weekly paclitaxel in previously untreated advanced non-small cell lung cancer (NSCLC)

✍ Krug, L.M; Miller, V.A; Crapanzano, J.P; Zakowski, M.F; Ng, K.K; Heelan, R.T; Ro 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Phase II and Phase III Trials: Docetaxel

Phase II and Phase III Trials: Docetaxel/Irinotecan versus Docetaxel/Cisplatin in Advanced Non–Small-Cell Lung Cancer (WJTOG 9803)

📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 70 KB

A randomized trial of cisplatin plus pac

A randomized trial of cisplatin plus paclitaxel versus cisplatin plus teniposide in advanced non-small cell lung cancer

✍ Giaccone, Giuseppe; Splinter, Ted A.W.; Postmus, Piet E.; Diaz-Puente, Maria; va 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 70 KB